Signature Cells Process: High-potency cells for more effective treatment.

Are you a candidate for BioXcellerator stem cell therapy?

Find out if stem cell therapy is right for you today!

Case Studies and Reports
painnews-bw2.jpg

Stem Cell Clinic for International Pain Patients By A. Rahman Ford, PNN Columnist

Published: November 15, 2020

stemcelltherapyforspinalcordinjury-bw2.jpg

Bioxcellerator treated 32 SCI patients with MSCs therapy. These charts show the baseline clinical characteristics of those patients.

Published: January 25, 2022

mscsforknees-bw2.jpg

Patients with spinal cord injuries often lose one of the basic five senses, the ability to feel. This can greatly impact a patient’s quality of life. 

Published: March, 5, 2021

mscsforknees2-bw2.jpg

BioXcellerator has been tracking their patients’ outcomes for over a year, and have granted us permission to share the following.

Published: September 8, 2022

clynicaltrials-bw2.jpg

Acute Respiratory Distress Syndrome Pipeline Drugs and Companies Report: Analysis of Clinical Trials, Therapies, Mechanism of Action.

Published: December 22, 2021

stemcelltherapyforspinalcordinjury2-bw2.jpg

Bioxcellerator treated 32 SCI patients with MSCs therapy. These charts show the baseline clinical characteristics of those patients.

Published: January 25, 2022

painnews-bw2.jpg

Stem Cell Clinic for International Pain Patients By A. Rahman Ford, PNN Columnist

Published: November 15, 2020

stemcelltherapyforspinalcordinjury-bw2.jpg

Bioxcellerator treated 32 SCI patients with MSCs therapy. These charts show the baseline clinical characteristics of those patients.

Published: January 25, 2022

mscsforknees-bw2.jpg

Patients with spinal cord injuries often lose one of the basic five senses, the ability to feel. This can greatly impact a patient’s quality of life. 

Published: March, 5, 2021

Scientific References, Citations and Articles

Chronic Pain

 

•    Looi, Qi Hao and Eng, Sue Ping and Liau, Ling Ling and Tor, Yin Sim and Mohd, Yazid Bajuri, and Ng, Min Hwei and Law, Jia Xian. Mesenchymal stem cell therapy for sports injuries - from research to clinical practice. Sains Malaysiana;2020.49(4):825-38. Available from: http://journalarticle.ukm.my/15354/

•    Trebinjac S, Gharairi M. Mesenchymal Stem Cells for Treatment of Tendon and Ligament Injuries-clinical Evidence. Med Arch. 2020 Oct;74(5):387-390. doi: 10.5455/medarh.2020.74.387-390. 

•    Kader N, Asopa V, Baryeh K, Sochart D, Maffulli N, Kader D. Cell-based therapy in soft tissue sports injuries of the knee: a systematic review. Expert Opin Biol Ther. 2021 Aug;21(8):1035-1047. doi: 10.1080/14712598.2021.1872538.

•    Baryeh K, Asopa V, Kader N, Caplan N, Maffulli N, Kader D. Cell-based therapies for the treatment of sports injuries of the upper limb. Expert Opinion on Biological Therapy. 2021;21(12):1561-74. DOI: 10.1080/14712598.2021.1928630

•    Stewart C. Stem cells and regenerative medicine in sport science. Emerg Top Life Sci. 2021;5(4): 563–73. doi: https://doi.org/10.1042/ETLS20210014

•    Song Y, Zhang J, Xu H, Lin Z, Chang H, Liu W, Kong L. Mesenchymal stem cells in knee osteoarthritis treatment: A systematic review and meta-analysis. J Orthop Translat. 2020 Apr 27;24:121-130. doi: 10.1016/j.jot.2020.03.015.

•    Cho WS, Chung SG, Kim W, Jo CH, Lee SU, Lee SY. Mesenchymal Stem Cells Use in the Treatment of Tendon Disorders: A Systematic Review and Meta-Analysis of Prospective Clinical Studies. Ann Rehabil Med. 2021 Aug;45(4):274-283. doi: 10.5535/arm.21078.

 

Autoimmune

•    Meng, M., Liu, Y., Wang, W., Wei, C., Liu, F., Du, Z., Xie, Y., Tang, W., Hou, Z., & Li, Q. Umbilical cord mesenchymal stem cell transplantation in the treatment of multiple sclerosis. American journal of translational research. 2018;10(1):212–23. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801359/


•    Riordan, N. H., Morales, I., Fernández, G., Allen, N., Fearnot, N. E., Leckrone, M. E., et al. Clinical feasibility of umbilical cord tissue-derived mesenchymal stem cells in the treatment of multiple sclerosis. Journal of translational medicine.2018;16(1):57. Available from: https://doi.org/10.1186/s12967-018-1433-7


•    Barczewska M, Grudniak M, Maksymowicz S, Siwek T, Oldak T, Jezierska-Wozniak K, et al. Safety of intrathecal injection of Wharton’s jelly derived mesenchymal stem cells in amyotrophic lateral sclerosis therapy. Neural Regen Res. 2019;14(2):313–8. https://pubmed.ncbi.nlm.nih.gov/30531015/


•    Leyendecker A Jr, Pinheiro CCG, Amano MT, Bueno DF. The Use of Human Mesenchymal Stem Cells as Therapeutic Agents for the in vivo Treatment of Immune-Related Diseases: A Systematic Review. Front Immunol. 2018 Sep 11;9:2056. doi: 10.3389/fimmu.2018.02056.


•    Cui, J., Jin, L., Ding, M. et al. Efficacy and safety of mesenchymal stem cells in the treatment of systemic sclerosis: a systematic review and meta-analysis. Stem Cell Res Ther 13, 118 (2022). https://doi.org/10.1186/s13287-022-02786-3


•    Reyes-Martínez V, Londoño J, Ávila-Portillo LM, Rueda JC, Padilla-Ortiz DM, Salgado D, et al . Mesenchymal stromal cells represent a therapeutic option for systemic sclerosis patients. Rev.Colomb.Reumatol. 2020;27(Suppl 1):126-34. Available from: https://doi.org/10.1016/j.rcreu.2020.02.007.

Find out if stem cell therapy could change your life.

 

Call one of our dedicated Patient Advocates today at 1-888-567-2469 or fill out the form to schedule your free consultation.